Al-Ali, H.A.H.; El-Tanani, M.; Satyam, S.M.; Al-Qaisi, T.S.; Lukman, Y.; Ahmed, K.A.; Obiedat, R.; Ibrahim, A.; Madi, R.; Khirfan, R.
Pimozide Reprograms the Ran GTPase–SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models. Cancers 2026, 18, 611.
https://doi.org/10.3390/cancers18040611
AMA Style
Al-Ali HAH, El-Tanani M, Satyam SM, Al-Qaisi TS, Lukman Y, Ahmed KA, Obiedat R, Ibrahim A, Madi R, Khirfan R.
Pimozide Reprograms the Ran GTPase–SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models. Cancers. 2026; 18(4):611.
https://doi.org/10.3390/cancers18040611
Chicago/Turabian Style
Al-Ali, Hayat Asaad Hameed, Mohammad El-Tanani, Shakta Mani Satyam, Talal Salem Al-Qaisi, Yusuf Lukman, Khaled A. Ahmed, Razan Obiedat, Abubakar Ibrahim, Razan Madi, and Rahmeh Khirfan.
2026. "Pimozide Reprograms the Ran GTPase–SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models" Cancers 18, no. 4: 611.
https://doi.org/10.3390/cancers18040611
APA Style
Al-Ali, H. A. H., El-Tanani, M., Satyam, S. M., Al-Qaisi, T. S., Lukman, Y., Ahmed, K. A., Obiedat, R., Ibrahim, A., Madi, R., & Khirfan, R.
(2026). Pimozide Reprograms the Ran GTPase–SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models. Cancers, 18(4), 611.
https://doi.org/10.3390/cancers18040611
